Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peribulbar and Subconjunctival Kenalog Injection for Thyroid Orbitopathy

NCT01280214 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.

NCT NCT01280214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01280214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peribulbar and Subconjunctival Kenalog Injection for Thyroid Orbitopathy
Lead sponsor
HaEmek Medical Center, Israel
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2011
Completion date
February 28, 2013
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid disease